Endocrine Abstracts

Introduction: Several treatments may be proposed against neuroendocrine tumors such as targeted therapies (Tyrosine kinase inhibitors: TKI) and somatostatin agonist. Since the first use of TKI in the oncological field, several studies have shown endocrine side effects type dysthyroidie. Several complex pathophysiological mechanisms and variable from one patient to another have been evoked ranging from a simple thyroiditis to complex autoimmune phenomena (cases of Basedow revea...